908 related articles for article (PubMed ID: 26988930)
1. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
2. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.
Fukuda M; Sakamaki K; Oba K
Clin Trials; 2023 Dec; 20(6):670-680. PubMed ID: 37455538
[TBL] [Abstract][Full Text] [Related]
3. Model selection for survival individualized treatment rules using the jackknife estimator.
Honvoh GD; Cho H; Kosorok MR
BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
[TBL] [Abstract][Full Text] [Related]
4. Robust versus consistent variance estimators in marginal structural Cox models.
Enders D; Engel S; Linder R; Pigeot I
Stat Med; 2018 Oct; 37(24):3455-3470. PubMed ID: 29888510
[TBL] [Abstract][Full Text] [Related]
5. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
Hsu CH; Taylor JM; Hu C
Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
[TBL] [Abstract][Full Text] [Related]
6. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
Kawahara T; Shinozaki T; Matsuyama Y
BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
[TBL] [Abstract][Full Text] [Related]
7. Regression models for the restricted residual mean life for right-censored and left-truncated data.
Cortese G; Holmboe SA; Scheike TH
Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
[TBL] [Abstract][Full Text] [Related]
8. Regression with a right-censored predictor using inverse probability weighting methods.
Matsouaka RA; Atem FD
Stat Med; 2020 Nov; 39(27):4001-4015. PubMed ID: 32779274
[TBL] [Abstract][Full Text] [Related]
9. The Kaplan-Meier Estimator as an Inverse-Probability-of-Censoring Weighted Average.
Satten GA; Datta S
Am Stat; 2001; 55(3):207-210. PubMed ID: 28845048
[TBL] [Abstract][Full Text] [Related]
10. Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.
Schaubel DE; Wei G
Biometrics; 2011 Mar; 67(1):29-38. PubMed ID: 20560935
[TBL] [Abstract][Full Text] [Related]
11. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
Latimer NR; Abrams KR; Siebert U
BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
[TBL] [Abstract][Full Text] [Related]
12. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
13. Consistent estimation of the expected Brier score in general survival models with right-censored event times.
Gerds TA; Schumacher M
Biom J; 2006 Dec; 48(6):1029-40. PubMed ID: 17240660
[TBL] [Abstract][Full Text] [Related]
14. Variable selection using inverse probability of censoring weighting.
Kojima M
Stat Methods Med Res; 2023 Nov; 32(11):2184-2206. PubMed ID: 37675496
[TBL] [Abstract][Full Text] [Related]
15. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
Hsu CH; Taylor JM
Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
[TBL] [Abstract][Full Text] [Related]
16. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
Díaz I; Colantuoni E; Hanley DF; Rosenblum M
Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
[TBL] [Abstract][Full Text] [Related]
17. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
Yoshida M; Matsuyama Y; Ohashi Y;
Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
[TBL] [Abstract][Full Text] [Related]
18. Reweighted estimators for additive hazard model with censoring indicators missing at random.
Chen X; Cai J
Lifetime Data Anal; 2018 Apr; 24(2):224-249. PubMed ID: 28766089
[TBL] [Abstract][Full Text] [Related]
19. Impact of censoring on learning Bayesian networks in survival modelling.
Stajduhar I; Dalbelo-Basić B; Bogunović N
Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
[TBL] [Abstract][Full Text] [Related]
20. Estimating lifetime or episode-of-illness costs under censoring.
Basu A; Manning WG
Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
